
Rockwell Medical (RMTI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Rockwell Medical (RMTI) last issued guidance on August 13, 2026 for fiscal year 2026. The company guided revenue in the range of $70M - $75M for the period.
Compared to prior guidance, Rockwell Medical maintained its revenue forecast from a prior range of $70M - $75M.
Rockwell Medical has issued 20 guidance updates between March 30, 2023 and August 13, 2026. During this period, the company raised its outlook 7 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-2.20 | $-0.20 | $0.30 | $-0.40 |
| Actual | $-0.40 | $-0.10 | $0.20 | $0.00 |
| Surprise | +81.8% | +50.0% | -33.3% | +100.0% |
| Revenue | ||||
| Estimate | $17.8M | $18.1M | $18.6M | $16.5M |
| Actual | $17.8M | $17.3M | $18.3M | $15.9M |
| Surprise | -0.32% | -4.24% | -1.23% | -3.27% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.21 | $-0.13 | $0.05 | $0.10 |
| Revenue | ||||
| Consensus | $18.3M | $19.0M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.40 | $-2.20 | 81.8 % |
| Q1 | May 7, 2026 | $-0.10 | $-0.20 | 50.0 % |
| Q4 | Mar 26, 2026 | $0.20 | $0.30 | -33.3 % |
| Q3 | Nov 12, 2025 | $0 | $-0.40 | 100.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $17.78M | $17.84M | -0.32 % |
| Q1 | May 7, 2026 | $17.34M | $18.10M | -4.24 % |
| Q4 | Mar 26, 2026 | $18.35M | $18.57M | -1.23 % |
| Q3 | Nov 12, 2025 | $15.93M | $16.46M | -3.27 % |